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graft impaired function in kidney recipients and the 
development of IC in liver recipients when using 
DCD grafts from the same donors. Kidney graft 
function could be a useful tool in order to predict 
liver complications in the DCD transplant setting in 
simultaneous liver-kideney DCD donation. 
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Introduction: During last few years total number 
of liver transplantations has rapidly increased. 
It is stated that in some cases postransplant 
complications are due to ischemia-reperfusion 
injury (IRI). IRI causes local injuries of the 
transplanted organ and is having an significant 
impact on transplantation success. Aim: The aim 
of our work was to evaluate the usefulness of bone 
marrow derived mesenchymal stem cells (MSCs) in 
limitation of liver IRI in a rat model. Material and 
Methods: In our study we have used 20 (6 week 
old) wistar rats. In all animals IRI was induced by 
use of the modification of hanging-weight system 
for liver ischemic preconditioning experimental 
technique. Then half of the animals were injected 
10x 6 MSC cells through the portal vein. The bone 
marrow mesenchymal stem cells were derived from 
the femur bones and cultivated in the standard 
incubation conditions. We have evaluated the 
morphology of culture and potential differentiation 
level. After sacrificing the animals formation of pro- 
and anti-inflammatory mediators, expression of 
adhesion molecules, and the role of oxidant stress 
during the inflammatory response were evaluated. 
Ethical committees permission was obtained and all 
research procedures were carried out in accordance 
with the guidelines of the relevant directives of 
the European Union in the field of experiments on 
animals. Results and Conclusion: MSCs attenuated 
the inflammatory and oxidant stress response and 
simultaneously reduced the effect of IRI in rat liver. 
In future MSCs might play a crucial role in reducing 
the number of complications connected with liver 
transplantation. 
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Introduction: DCD donors have been proposed to 
partially overcome the organ donor shortage. DCD-
LT remains controversial, with reported increased 
risk of graft failure and ischemic type biliary tract 
lesions. The authors retrospectively reviewed a single 
centre experience with DCD-LT in a 9-year period. 
Patients and Methods: 70 DCD-LT were performed 
from 2003 to November 2012. All DCD procedures 
were performed in operative rooms. Mean donor age 
was 56 years. Most grafts were flushed with HTK 
solution. Allocation was centre-based. Mean total 
DCD warm ischemia was 20.5 min. Mean follow-up 
was 36 months. No patient was lost to follow-up. 
Results: Mean MELD score at LT was 15. Mean cold 
ischemia was 254 min. Mean peak AST was 2,330 
U/L. Mean peak bilirubin was 45 mg/dL. Patient 
and graft survivals were 92.8% and 91.3% at one 
year and 79% and 77.7% at 3 years, respectively. 
One graft was lost due to hepatic artery thrombosis. 
No PNF or graft loss due to IBDL was observed in 
this series. Causes of death were malignancies in 8 
cases. Discussion: In this series, DCD LT appears 
to provide results equal to classical LT. Short cold 
ischemia and recipient selection with low MELD 
score may be the keys to good results in DCD LT, in 
terms of graft survival and avoidance of IBDL. 
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Background. Donors after circulatory death (DCD) 
are valuable source of organs. However, liver 
transplantation (LTx) using DCD livers is associated 
with inferior graft survival and higher rate of biliary 
complications. This single center, retrospective 
study analyzed the outcome of LTx from DCD with 
respect to patient and graft survival as well as biliary 
complications rate. Additional search was made for 
the risk factors for the outcome. Material/methods. 
Between November 1, 2002 and December 31, 
2011 sixty-three livers out of 408 (15.7%) were 
transplanted from DCD. The review of prospectively 
collected donor, recipient and transplant data was 
performed. Results. Overall patient survival at 1-, 3 
and 5-year was 84%, 77% and 65%, respectively. 
Overall graft survival at the same time points 
